Presentation is loading. Please wait.

Presentation is loading. Please wait.

Public Sector Donors Who Increased Funding for HIV Vaccine R&D in 2011 How much did donor funding increase?

Published byFrancis Lawrence Patterson Modified over 9 years ago

Similar presentations

Presentation on theme: "Public Sector Donors Who Increased Funding for HIV Vaccine R&D in 2011 How much did donor funding increase?"— Presentation transcript:

1 Public Sector Donors Who Increased Funding for HIV Vaccine R&D in 2011 How much did donor funding increase?

2 Philanthropic Investment in HIV Vaccine R&D by Foundations and Commercial Philanthropy in 2011 (US$)

3 Estimated Commercial Engagement in HIV Vaccine R&D by Company in 2011

4 Annual Investments in Microbicide R&D from 2006–2011 (US$ millions)*

5 Microbicide Funding from 2000–2011 (US$ millions)

6 Top Microbicide Funders for 2010 and 2011 (US$ millions)

7 Microbicide Funding from 2000–2011 (US$ millions)

8 Microbicide Expenditures from 2000–2011 (US$ millions)

9 Investment in Pre-Exposure Prophylaxis from 2005–2011 (US$ millions)

10 Annual Investments in Pre-Exposure Prophylaxis from 2005–2011 (US$ millions)

11 Funding for Vertical Transmission Prevention from R&D 2008–2011 (US$ millions)

12 Funding for Female Condom R&D in 2010 and 2011

13 Categories Used to Classify Preventive HIV Vaccine R&D Funding

14 Categories Used to Classify Microbicide R&D Funding

Download ppt "Public Sector Donors Who Increased Funding for HIV Vaccine R&D in 2011 How much did donor funding increase?"

Similar presentations

From “What If” to “What Now” Perspectives on ARVs and the Future of Treatment and Prevention Mitchell Warren Executive Director, AVAC IAS 2011, Rome.

From “What If” to “What Now” Perspectives on ARVs and the Future of Treatment and Prevention Mitchell Warren Executive Director, AVAC IAS 2011, Rome.
W.K. Kellogg Foundation: Giving In Communities of Color Fostering An Equitable and Responsive Philanthropic Sector.

W.K. Kellogg Foundation: Giving In Communities of Color Fostering An Equitable and Responsive Philanthropic Sector.
HIV Prevention Research & Development Investment in 2013 In a changing global development, economic, and human rights landscape Presented at the International.

HIV Prevention Research & Development Investment in 2013 In a changing global development, economic, and human rights landscape Presented at the International.
COMPANION GRAPHS. Annual Global Plan Research Funding Targets vs. 2011 Investments $800,000,000 $600,000,000 $400,000,000 $200,000,000 $0 Fundamental.

COMPANION GRAPHS. Annual Global Plan Research Funding Targets vs Investments $800,000,000 $600,000,000 $400,000,000 $200,000,000 $0 Fundamental.
National Working Group on Microbicides Microbicides advocacy Paramita Kundu & Ananthy Thambinayagam Global Campaign for Microbicides, PATH January 2007.

National Working Group on Microbicides Microbicides advocacy Paramita Kundu & Ananthy Thambinayagam Global Campaign for Microbicides, PATH January 2007.
How well are we doing in preventing HIV and how can we do better?

How well are we doing in preventing HIV and how can we do better?
People receiving antiretroviral therapy, 2005 to June 2014, all countries.

People receiving antiretroviral therapy, 2005 to June 2014, all countries.
Epidemiology of HIV and Access to Prevention services, Tanzania Joint Biennial HIV National Response Review Stakeholders meeting. November, 2014 Blue Pearl.

Epidemiology of HIV and Access to Prevention services, Tanzania Joint Biennial HIV National Response Review Stakeholders meeting. November, 2014 Blue Pearl.
WHAT IS GOING ON IN HIV AND AIDS IN 2013 AND BEYOND Prof Alan Whiteside RATN MEETING JOHANNESBURG March 2013.

WHAT IS GOING ON IN HIV AND AIDS IN 2013 AND BEYOND Prof Alan Whiteside RATN MEETING JOHANNESBURG March 2013.
Results of the Community Foundations mapping project: what we’ve learned and what comes next. Louise Arkles, ACP Discussion facilitated by Alexandra Gartmann.

Results of the Community Foundations mapping project: what we’ve learned and what comes next. Louise Arkles, ACP Discussion facilitated by Alexandra Gartmann.
Rectal Microbicides: The Basics Date, Location Your Name, Organization.

Rectal Microbicides: The Basics Date, Location Your Name, Organization.
International HIV Assistance from Donor Governments: Commitments & Disbursements, 2002-2013 US$ Billions Commitments (Enacted Amounts) Disbursements SOURCES:

International HIV Assistance from Donor Governments: Commitments & Disbursements, US$ Billions Commitments (Enacted Amounts) Disbursements SOURCES:
© 2014 SAGE Publications, Inc. Chapter 2: Overview of the Nonprofit Sector.

© 2014 SAGE Publications, Inc. Chapter 2: Overview of the Nonprofit Sector.
CROWDFUNDING FOR A CAUSE HOW BROAD BASED FUNDING MODELS ARE CHANGING TRADITIONAL PHILANTHROPY GARRETT GOLDBERG IDAHO NONPROFIT CENTER – 10 TH ANNUAL CONFERENCE.

CROWDFUNDING FOR A CAUSE HOW BROAD BASED FUNDING MODELS ARE CHANGING TRADITIONAL PHILANTHROPY GARRETT GOLDBERG IDAHO NONPROFIT CENTER – 10 TH ANNUAL CONFERENCE.
International HIV Assistance from Donor Governments: Commitments & Disbursements, 2002-2012 US$ Billions Commitments (Enacted Amounts) Disbursements SOURCES:

International HIV Assistance from Donor Governments: Commitments & Disbursements, US$ Billions Commitments (Enacted Amounts) Disbursements SOURCES:
HIV/AIDS Treatment and Care Clinical protocols for the WHO European Region 23 November 2007 World AIDS Day Jeffrey V. Lazarus WHO Europe, STI/HIV/AIDS.

HIV/AIDS Treatment and Care Clinical protocols for the WHO European Region 23 November 2007 World AIDS Day Jeffrey V. Lazarus WHO Europe, STI/HIV/AIDS.
Creating an AIDS-Free Generation The beginning of the end of AIDS Center for Strategic & International Studies Washington, DC March 22, 2012 Thomas R.

Creating an AIDS-Free Generation The beginning of the end of AIDS Center for Strategic & International Studies Washington, DC March 22, 2012 Thomas R.
T reatment A ction G roup Update on Global TB Research By Claire Wingfield Treatment Action Group Advisory Council for the Elimination of Tuberculosis.

T reatment A ction G roup Update on Global TB Research By Claire Wingfield Treatment Action Group Advisory Council for the Elimination of Tuberculosis.
2005–2012 NIH Funding for Select Infectious Diseases (in Millions) * Includes ARRA stimulus funds National Institutes of Health (U.S.). Estimates of funding.

2005–2012 NIH Funding for Select Infectious Diseases (in Millions) * Includes ARRA stimulus funds National Institutes of Health (U.S.). Estimates of funding.
Www.global-campaign.org Microbicides: Who, what, where, when and how Rebekah Webb Global Campaign for Microbicides www.global-campaign.org © Salam Dahbor,

Microbicides: Who, what, where, when and how Rebekah Webb Global Campaign for Microbicides © Salam Dahbor,

Similar presentations

Ads by Google